Join to View Full Profile
1428 Madison Ave Bldg 6thNew York, NY 10029
Phone+1 212-241-8484
Are you Dr. Santos-Gallego?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Publications & Presentations
PubMed
- Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial.Christiane E Angermann, Susanne Sehner, Louisa M S Gerhardt, Carlos G Santos-Gallego, Juan Antonio Requena-Ibanez
European Heart Journal. 2025-02-05 - 8 citationsRationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.Maeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, Carlos G Santos-Gallego, M Urooj Zafar
Cardiovascular Drugs and Therapy. 2025-02-01 - Machine learning in the prevention of heart failure.Arsalan Hamid, Matthew W Segar, Biykem Bozkurt, Carlos Santos-Gallego, Vijay Nambi
Heart Failure Reviews. 2025-01-01
Press Mentions
Sotagliflozin Reduces Ischemic Risk in SCORED AnalysisFebruary 25th, 2025- Some BP Meds Tied to Significantly Lower Risk for Dementia, Alzheimer’sJanuary 11th, 2023
- Empagliflozin Favorably Reshaped Left Ventricles in HFrEF PatientsNovember 15th, 2020
- Join now to see all
